Proposed Data Collections Submitted for Public Comment and Recommendations, 15748-15749 [E6-4550]
Download as PDF
15748
Federal Register / Vol. 71, No. 60 / Wednesday, March 29, 2006 / Notices
addition, the completed public health
assessments are available by mail
through the U.S. Department of
Commerce, National Technical
Information Service (NTIS), 5285 Port
Royal Road, Springfield, Virginia 22161,
or by telephone at (800) 553–6847. NTIS
charges for copies of public health
assessments. The NTIS order numbers
are listed in parentheses following the
site names.
Public Health Assessments Completed
or Issued
Between October 1, 2005, and
December 31, 2005, public health
assessments were issued for the sites
listed below:
Dated: March 16, 2006.
Kenneth Rose,
Acting Director, Office of Policy, Planning,
and Evaluation, National Center for
Environmental Health, Agency for Toxic
Substances and Disease Registry.
[FR Doc. E6–4554 Filed 3–28–06; 8:45 am]
BILLING CODE 4163–70–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–06–0571]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
NPL and Proposed NPL Sites
Florida
United Metals, Incorporated—
(PB2006–100865).
Georgia
Cedartown Industries, Incorporated—
(PB2006–102395).
Hawaii
Pearl Harbor Naval Complex—
(PB2006–102414)
Massachusetts
Hatheway and Patterson Company—
(PB2006–100884).
Missouri
Madison County Mines Site—
(PB2006–101990).
New York
Lawrence Aviation Industries—
(PB2006–101529).
Stanton Cleaners Area Groundwater
Contamination Site—(PB2006–101530).
Tennessee
TSCA Incinerator—U.S. Department
of Energy Oak Ridge Reservation—
(PB2006–103434).
Non-NPL Petitioned Sites
Florida
The Lincoln Park Complex—
(PB2006–100864).
hsrobinson on PROD1PC68 with NOTICES
Georgia
L & B Recycling, Incorporated—
(PB2006–100885).
New York
Norlite Corporation—(PB2006–
101989).
VerDate Aug<31>2005
15:39 Mar 28, 2006
Jkt 208001
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Seleda Perryman,
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Minimum Data Elements (MDEs)/
System for Technical Assistance
Reporting (STAR) for the National
Breast and Cervical Cancer Early
Detection Program (NBCCEDP)—
Revision—National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
Background and Brief Description
The NBCCEDP was established in
response to the Congressional Breast
and Cervical Cancer Mortality
Prevention Act of 1990. This Act
mandates a program that will provide
early detection and breast and cervical
cancer screening services for underserved women.
CDC proposes to aggregate breast and
cervical cancer screening, diagnostic,
and treatment data from NBCCEDP
grantees at the state, territory, and tribal
level. These aggregated data will
include demographic information about
women served through funded
programs. The proposed data collection
will also include infrastructure data
about grantee management, public
education and outreach, professional
education, and service delivery.
Breast cancer is a leading cause of
cancer-related death among American
women. The American Cancer Society
(ACS) estimated that 211,240 new cases
would be diagnosed among women in
2005, and 40,410 women would die of
this disease. Mammography is
extremely valuable as an early detection
tool because it can detect breast cancer
well before the woman can feel the
lump, when it is still in an early and
more treatable stage. Women older than
age 40 that receive annual
mammography screening reduce their
probability of breast cancer mortality
and increase their treatment options.
Although early detection efforts have
greatly decreased the incidence of
invasive cervical cancer in recent
decades, ACS estimated that 10,370 new
cases would be diagnosed in 2005 and
3,710 women would die of this disease.
Papanicolaou (Pap) tests effectively
detect precancerous lesions in addition
to invasive cervical cancer. The
detection and treatment of precancerous
lesions can prevent nearly all cervical
cancer-related deaths.
Because breast and cervical cancer
screening, diagnostic and treatment data
are already collected and aggregated at
the state, territory and tribal level, the
additional burden on the grantees will
be small. Continuation of this program
will require grantees to report a
minimum data set (MDE) on screening
and follow-up activities electronically to
the CDC on a semi-annual basis. The
program will require grantees to report
infrastructure data (STAR) to the CDC
annually using a web-based system.
Information collected will be used to
obtain more complete breast and
cervical cancer data, promote public
education of cancer incidence and risk,
improve the availability of screening
and diagnostic services for under-served
E:\FR\FM\29MRN1.SGM
29MRN1
15749
Federal Register / Vol. 71, No. 60 / Wednesday, March 29, 2006 / Notices
women, ensure the quality of services
provided to women, and develop
outreach strategies for women that are
never or rarely screened for breast and
respondents except their time to
participate in the survey.
cervical cancer. Data collection will
continue for the next three years. The
average annual burden for this effort is
1,972 hours. There are no costs to
ESTIMATED ANNUALIZED BURDEN TABLE
Number of
respondents
Respondents
Average
burden per
response
(in hrs.)
Number of
responses per
respondent
Total burden
hours
*Infrastructure Report (STAR) .........................................................................
*Screening and Follow-up ...............................................................................
68
68
1
1
25
4
1700
272
Total ..........................................................................................................
........................
........................
........................
1972
*Respondents include State, Territorial and Tribal grantees.
Dated: March 22, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–4550 Filed 3–28–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Proposed Project
Requirement for a Special Permit to
Import Cynomolgus, African Green, or
Rhesus Monkeys into the United States
(0920–0263)—Extension—National
Center for Infectious Diseases (NCID),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Centers for Disease Control and
Prevention
[30Day–06–0263]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974. Written
comments should be received within 30
days of this notice.
A registered importer must request a
special permit to import Cynomolgus,
African Green, or Rhesus Monkeys. To
receive a special permit to import
nonhuman primates the importer must
submit to the Director of CDC, a written
plan which specifies the steps that will
be taken to prevent exposure of persons
and animals during the entire
importation and quarantine process for
the arriving nonhuman primates.
Under the special permit
arrangement, registered importers must
submit a plan to CDC for the
importation and quarantine if they wish
to import the specific monkeys covered.
The plan must address disease
prevention procedures to be carried out
in every step of the chain of custody of
such monkeys, from embarkation in the
country of origin to release from
quarantine. Information such as species,
origin and intended use for monkeys,
transit information, isolation and
quarantine procedures, and procedures
for testing of quarantined animals is
necessary for CDC to make public health
decisions. This information enables
CDC to evaluate compliance with the
standards and to determine whether the
measures being taken to prevent
exposure of persons and animals during
importation are adequate. Once CDC is
assured, through the monitoring of
shipments (normally no more than 2),
that the provisions of a special permit
plan are being followed by a new permit
holder and that the use of adequate
disease control practices is being
demonstrated, the special permit is
extended to cover the receipt of
additional shipments under the same
plan for a period of 180 days, and may
be renewed upon request. This
eliminates the burden on importers to
repeatedly report identical information,
requiring only that specific shipment
itineraries and information on changes
to the plan which require approval be
submitted.
Respondents are commercial or notfor-profit importers of nonhuman
primates. The burden represents full
submission of information and
itinerary/change information
respectively. There are no costs to
respondents except for their time to
complete the requisition process. The
total estimated annual burden hours are
20.
ESTIMATED ANNUALIZED BURDEN
Number of
respondents
hsrobinson on PROD1PC68 with NOTICES
Respondents
Businesses (limited permit) .........................................................................................................
Businesses (extended permit) .....................................................................................................
Organizations (extended permit) .................................................................................................
VerDate Aug<31>2005
17:39 Mar 28, 2006
Jkt 208001
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
E:\FR\FM\29MRN1.SGM
Number of
responses per
respondent
2
3
15
29MRN1
5
5
5
Average
burden per
response
(in hours)
30/60
10/60
10/60
Agencies
[Federal Register Volume 71, Number 60 (Wednesday, March 29, 2006)]
[Notices]
[Pages 15748-15749]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-4550]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-06-0571]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960
and send comments to Seleda Perryman, CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Minimum Data Elements (MDEs)/System for Technical Assistance
Reporting (STAR) for the National Breast and Cervical Cancer Early
Detection Program (NBCCEDP)--Revision--National Center for Chronic
Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The NBCCEDP was established in response to the Congressional Breast
and Cervical Cancer Mortality Prevention Act of 1990. This Act mandates
a program that will provide early detection and breast and cervical
cancer screening services for under-served women.
CDC proposes to aggregate breast and cervical cancer screening,
diagnostic, and treatment data from NBCCEDP grantees at the state,
territory, and tribal level. These aggregated data will include
demographic information about women served through funded programs. The
proposed data collection will also include infrastructure data about
grantee management, public education and outreach, professional
education, and service delivery.
Breast cancer is a leading cause of cancer-related death among
American women. The American Cancer Society (ACS) estimated that
211,240 new cases would be diagnosed among women in 2005, and 40,410
women would die of this disease. Mammography is extremely valuable as
an early detection tool because it can detect breast cancer well before
the woman can feel the lump, when it is still in an early and more
treatable stage. Women older than age 40 that receive annual
mammography screening reduce their probability of breast cancer
mortality and increase their treatment options.
Although early detection efforts have greatly decreased the
incidence of invasive cervical cancer in recent decades, ACS estimated
that 10,370 new cases would be diagnosed in 2005 and 3,710 women would
die of this disease. Papanicolaou (Pap) tests effectively detect
precancerous lesions in addition to invasive cervical cancer. The
detection and treatment of precancerous lesions can prevent nearly all
cervical cancer-related deaths.
Because breast and cervical cancer screening, diagnostic and
treatment data are already collected and aggregated at the state,
territory and tribal level, the additional burden on the grantees will
be small. Continuation of this program will require grantees to report
a minimum data set (MDE) on screening and follow-up activities
electronically to the CDC on a semi-annual basis. The program will
require grantees to report infrastructure data (STAR) to the CDC
annually using a web-based system. Information collected will be used
to obtain more complete breast and cervical cancer data, promote public
education of cancer incidence and risk, improve the availability of
screening and diagnostic services for under-served
[[Page 15749]]
women, ensure the quality of services provided to women, and develop
outreach strategies for women that are never or rarely screened for
breast and cervical cancer. Data collection will continue for the next
three years. The average annual burden for this effort is 1,972 hours.
There are no costs to respondents except their time to participate in
the survey.
Estimated Annualized Burden Table
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Respondents respondents responses per response (in hours
respondent hrs.)
----------------------------------------------------------------------------------------------------------------
*Infrastructure Report (STAR)................... 68 1 25 1700
*Screening and Follow-up........................ 68 1 4 272
---------------------------------------------------------------
Total....................................... .............. .............. .............. 1972
----------------------------------------------------------------------------------------------------------------
*Respondents include State, Territorial and Tribal grantees.
Dated: March 22, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E6-4550 Filed 3-28-06; 8:45 am]
BILLING CODE 4163-18-P